CLSD - Clearside Biomedical Insider Trades Send a Signal | Benzinga
Bradford T Whitmore, 10% Owner at Clearside Biomedical (NASDAQ:CLSD), reported a large insider buy on November 1, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Whitmore purchased 135,778 shares of Clearside Biomedical. The total transaction amounted to $99,849.
Clearside Biomedical shares are trading down 4.99% at $0.72 at the time of this writing on Thursday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In legal terms, an "insider" refers to any officer, ...